Patent · US Active

Organic compounds

US7994203B2 · kind B2 · utility

0Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 3, 2009
Grant dateAug 9, 2011
Priority date—
Expiry dateAug 3, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There are described pyrazolo[5.1-b]oxazole derivatives useful as corticotropin releasing factor (CRF1) receptor antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.